Friedman M L, Ball W J
Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, OH 45267-0575.
Biochim Biophys Acta. 1989 Mar 16;995(1):42-53. doi: 10.1016/0167-4838(89)90231-8.
The fluorescein 5'-isothiocyanate (FITC)-labeled lamb kidney Na+/K+-ATPase has been used to investigate enzyme function and ligand-induced conformational changes. In these studies, we have determined the effects of two monoclonal antibodies, which inhibit Na+/K+-ATPase activity, on the conformational changes undergone by the FITC-labeled enzyme. Monitoring fluorescence intensity changes of FITC-labeled enzyme shows that antibody M10-P5-C11, which inhibits E1 approximately P intermediate formation (Ball, W.J. (1986) Biochemistry 25, 7155-7162), has little effect on the E1 in equilibrium E2 transitions induced by Na+, K+, Mg2+ Pi or Mg2+. ouabain. The M10-P5-C11 epitope, which appears to reside near the ATP-binding site, does not significantly participate in these ligand interactions. In contrast, we find that antibody 9-A5 (Schenk, D.B., Hubert, J.J. and Leffert, H.L. (1984) J. Biol. Chem. 259, 14941-14951) inhibits both the Na+/K+-ATPase and p-nitrophenylphosphatase activity. Its binding produces a 'Na+-like' enhancement in FITC fluorescence, reduces the ability of K+ to induce the E1 in equilibrium E2 transition and converts E2.K+ to an E1 conformation. Mg2+ binding to the enzyme alters both the conformation of this epitope region and its coupling of ligand interactions. In the presence of Mg2+, 9-A5 binding stabilizes an E1.Mg2+ conformation such that K+-, Pi- and ouabain-induced E1----E2 or E1----E2-Pi transitions are inhibited. Oubain and Pi added together overcome this stabilization. These studies indicate that the 9-A5 epitope participates in the E1 in equilibrium E2 conformational transitions, links Na+-K+ interactions and ouabain extracellular binding site effects to both the phosphorylation site and the FITC-binding region. Antibody-binding studies and direct demonstration of 9-A5 inhibition of enzyme phosphorylation by [32P]Pi confirm the results obtained from the fluorescence studies. Antibody 9-A5 has also proven useful in demonstrating the independence of Mg2+ ATP and Mg2+Pi regulation of ouabain binding. In addition, [3H]ouabain and antibody-binding studies demonstrate that FITC-labeling alters the enzyme's responses to Mg2+ as well as ATP regulation.
异硫氰酸荧光素(FITC)标记的羊肾Na⁺/K⁺-ATP酶已被用于研究酶的功能和配体诱导的构象变化。在这些研究中,我们确定了两种抑制Na⁺/K⁺-ATP酶活性的单克隆抗体对FITC标记酶所经历的构象变化的影响。监测FITC标记酶的荧光强度变化表明,抑制E1向P中间体形成的抗体M10-P5-C11(Ball, W.J. (1986) Biochemistry 25, 7155 - 7162)对由Na⁺、K⁺、Mg²⁺、Pi或Mg²⁺、哇巴因诱导的E1在平衡E2转变中几乎没有影响。M10-P5-C11表位似乎位于ATP结合位点附近,并未显著参与这些配体相互作用。相反,我们发现抗体9-A5(Schenk, D.B., Hubert, J.J. and Leffert, H.L. (1984) J. Biol. Chem. 259, 14941 - 14951)既抑制Na⁺/K⁺-ATP酶活性,也抑制对硝基苯磷酸酶活性。其结合在FITC荧光中产生“类似Na⁺”的增强作用,降低K⁺诱导E1在平衡E2转变中的能力,并将E2.K⁺转化为E1构象。Mg²⁺与酶的结合改变了该表位区域的构象及其与配体相互作用的偶联。在Mg²⁺存在下,9-A抗体结合稳定了E1.Mg²⁺构象,从而抑制K⁺、Pi和哇巴因诱导的E1→E2或E1→E2-Pi转变。一起添加哇巴因和Pi可克服这种稳定作用。这些研究表明,9-A5表位参与E1在平衡E2构象转变中,将Na⁺-K⁺相互作用和哇巴因细胞外结合位点效应与磷酸化位点以及FITC结合区域联系起来。抗体结合研究以及9-A5对[³²P]Pi酶磷酸化抑制作用的直接证明证实了从荧光研究中获得的结果。抗体9-A5在证明Mg²⁺-ATP和Mg²⁺-Pi对哇巴因结合调节的独立性方面也已证明是有用的。此外,[³H]哇巴因和抗体结合研究表明,FITC标记改变了酶对Mg²⁺以及ATP调节的反应。